Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Cycloalkane carboxylic acid derivatives as CXCR3 receptor antagonists

Cycloalkane carboxylic acid derivatives as CXCR3 receptor antagonists

US Patent 9073853 · Granted Jul 7, 2015

Estimated economic value: $15,591,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Pharmaceutically effective compounds inhibiting selectively the myosin 2 isoform2025
Pharmaceutically effective compounds inhibiting selectively the myosin 2 isoform2023
Pharmaceutically effective compounds inhibiting selectively the myosin 2 isoform2023
Substituted piperidines as inhibitors of ubiquitin specific protease 72022
Triazolobenzazepines as vasopressin V1a receptor antagonists2022
Substituted piperidines for the treatment of cancer2021
(Hetero)aryl-substituted-piperidinyl derivatives, a process for their preparatio2020
Substituted B-amino acid derivatives as CXCR3 receptor antagonists2016
Substituted B-amino acid derivatives as CXCR3 receptor antagonists2016
Substituted B-amino acid derivatives as CXCR3 receptor antagonists2016
Substituted B-amino acid derivatives as CXCR3 receptor antagonists2016
Substituted B-amino acid derivatives as CXCR3 receptor antagonists2016